课题基金 / 基金详情

The Impact of the SARS-CoV-2 Virus on the Integrity of the Blood-brain Barrier

The Impact of the SARS-CoV-2 Virus on the Integrity of the Blood-brain Barrier
SARS-CoV-2 病毒对血脑屏障完整性的影响
批准号:
2034780
负责人:
Peter Galie
金额:
$29.98万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2024-08-31

项目摘要

项目成果

Peter Galie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continues to detrimentally impact the prosperity and welfare of our country. As such, fundamental studies are needed to understand the effects of the virus on the organ systems in the body. In these patients, stroke and delirium are not uncommon. These conditions are associated with breakdown of the blood-brain barrier, which is unique to blood vessels in the central nervous system. The work done with this award will study how the spike protein of the virus affects the blood-brain barrier. Specifically, the junctions between cells lining the inside of blood vessels will be studied. The overall goal is to identify the mechanisms underlying the response to the spike protein. The results of this work may suggest new treatment strategies to mitigate the neurological effects of the SARS-CoV-2 virus. This research will be combined with a program to film instructional on-demand science videos for middle and high school science teachers who are teaching remotely during the COVID-19 pandemic.The hypothesis is that binding of the SARS-CoV-2 spike protein to angiotensin converting enzyme 2 (ACE2) disrupts the blood-brain barrier by inhibiting the protective effect of fluid shear stress mediated by RhoA signaling. Recent studies using samples from human patients have demonstrated that vasculature in the brain expresses ACE2, the primary target for the SARS-CoV-2 virus, but the effects of spike protein-mediated inactivation of ACE2 on the integrity of the blood-brain barrier remain unclear. Here, the studies will use a three-dimensional in vitro model of the blood-brain barrier to interrogate the mechanotransduction mechanisms responsible for the endothelial response to the S1 peptide of the spike protein in the presence of fluid shear stress, accounting for both short-term, cytoskeletal-mediated pathways and long-term, transcriptional changes in the endothelial cells. These studies will elucidate the mechanistic basis for breakdown of the blood-brain barrier in response to coronaviruses such as SARS-CoV-2. The results may explain the increased incidence of stroke and other neuropathologies that occur secondary to the COVID-19 virus.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.nbd.2020.105131
发表时间: 2020-12
期刊: Neurobiology of disease
影响因子: 6.1
作者: [Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, Razmpour R, Hale JF, Galie PA, Potula R, Andrews AM, Ramirez SH]
通讯作者: Ramirez SH
DOI: 10.1002/jcp.30840
发表时间: 2022-07-28
期刊: JOURNAL OF CELLULAR PHYSIOLOGY
影响因子: 5.6
作者: [Tran,Kiet A., Baldwin-Leclair,Abigail, Galie,Peter A.]
通讯作者: Galie,Peter A.
I-Corps: A conductive scaffold with a tunable mechanical and biochemical environment for spinal cord injury repair
  • 批准号:
    2337356
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2023
  • 负责人:
    Peter Galie
  • 依托单位:
Astrocyte Mechanobiology Following Central Nervous System Injury Revealed By Magnetically Active Hydrogels
  • 批准号:
    2223318
  • 项目类别:
    Standard Grant
  • 资助金额:
    $29.92万
  • 财政年份:
    2022
  • 负责人:
    Peter Galie
  • 依托单位:
RUI: Probing the Mechanotransduction of Disturbed Flow in Brain Vasculature
  • 批准号:
    1728239
  • 项目类别:
    Standard Grant
  • 资助金额:
    $29.89万
  • 财政年份:
    2017
  • 负责人:
    Peter Galie
  • 依托单位:
国内基金
海外基金
SUMO化介导泛素化修饰类型调控N蛋白水平及SARS-CoV-2复制的机制研究
  • 批准号:
    JCZRQN202500077
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
SARS-CoV-2 VLP调控肿瘤微环境影响三阴性乳腺癌发生发展的机制 研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
  • 依托单位:
靶向SARS-CoV-2 S1蛋白中药多糖活性化合物的筛选及构效关系研究